DOYLESTOWN, PA -- (MARKET WIRE) -- April 19, 2007 -- QuantRx® Biomedical Corporation (OTCBB: QTXB), an emerging leader in the development and commercialization of medical diagnostic platforms and products, today announced that it has increased its holdings in FluoroPharma, Inc., a Boston-based molecular imaging company, to a controlling interest.
